Abstract

The anemia and inflammation concurrent with blood stage malaria trigger stress haematopoiesis and erythropoiesis. The activity of osteoclasts seems required for the mobilization of hematopoietic stem and progenitor cells (HSPC) from the bone marrow to the periphery. Knowing that BALB/c mice with acute Plasmodium chabaudi adami malaria have profound alterations in bone remodelling cells, we evaluated the extent to which osteoclasts influence their hematopoietic response to infection. For this, mice were treated with osteoclast inhibiting hormone calcitonin prior to parasite inoculation, and infection as well as hematological parameters was studied. In agreement with osteoclast-dependent HSPC mobilization, administration of calcitonin led to milder splenomegaly, reduced numbers of HSPC in the spleen, and their retention in the bone marrow. Although C-terminal telopeptide (CTX) levels, indicative of bone resorption, were lower in calcitonin-treated infected mice, they remained comparable in naive and control infected mice. Calcitonin-treated infected mice conveniently responded to anemia but generated less numbers of splenic macrophages and suffered from exacerbated infection; interestingly, calcitonin also decreased the number of macrophages generated in vitro. Globally, our results indicate that although osteoclast-dependent HSC mobilization from bone marrow to spleen is triggered in murine blood stage malaria, this activity is not essential for stress erythropoiesis.

Highlights

  • Quiescent hematopoietic stem cells (HSCs) reside in the bone marrow (BM) near the endosteum, in specific microenvironments called endosteal niches [1,2,3]

  • Contradictory evidences demonstrate that inhibition of osteoclast activity by bisphosphonate does not impair hematopoietic stem and progenitor cells (HSPC) mobilization in response to Granulocyte-Colony Stimulating Factor (G-CSF) treatment [1, 10], suggesting that osteoclasts may only intervene in certain types of hematopoietic stresses

  • We recently reported profound alterations in bone remodelling in mice with malarial or PHZ-induced hemolytic anemia [33], characterized by decreased bone formation, reduced osteoclastogenesis, and balance resulting in bone mass loss

Read more

Summary

Introduction

Quiescent hematopoietic stem cells (HSCs) reside in the bone marrow (BM) near the endosteum, in specific microenvironments called endosteal niches [1,2,3]. Recent studies involve bone resorbing osteoclasts in the homeostasis and mobilization of HSC and hematopoietic progenitor cells (HSPC) in conditions of stress, this function remains controversial [8,9,10,11]. Stimulation of osteoclasts activity by Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) increases HSPC mobilization through secretion of cathepsin K, which cleaves c-Kit-ligand and Stromal Cell-Derived Factor 1 (SDF1), required for maintenance of endosteal niches. The osteoclast inhibiting hormone calcitonin was reported to decrease HSPC mobilization in response to LPS injection [11]. Contradictory evidences demonstrate that inhibition of osteoclast activity by bisphosphonate does not impair HSPC mobilization in response to Granulocyte-Colony Stimulating Factor (G-CSF) treatment [1, 10], suggesting that osteoclasts may only intervene in certain types of hematopoietic stresses

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call